Search results
Results from the WOW.Com Content Network
Percutaneous ethanol injection is a possible treatment for hepatocellular carcinoma. [1] Also used for thyroid and parathyroid disease. [2] Instead of removing unwanted tissue surgically it is killed with alcohol. [citation needed] It is similar in mechanism to Alcohol septal ablation for heart problems.
Percutaneous ethanol injection is well tolerated in small (<3 cm) solitary tumors. Local therapy can achieve a 5-year survival rate around 60% for patients with small HCC. Local therapy can achieve a 5-year survival rate around 60% for patients with small HCC.
When resection for cure is not possible (R0 resection), percutaneous ethanol injection has been suggested to dehydrate and kill the tumour cells, however there is not enough evidence to determine the effectiveness and safety of this approach.
Tumor vascularity and lens culinaris agglutinin reactive alpha-fetoprotein are predictors of long-term prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy. Fukuda, H., Kurume Med. J., 45, 187–193, 1998.
Chemical ablation: one of the earliest ablative techniques involving the injection of substances such as ethanol or acetic acid into a tumour to cause protein denaturation and cell death. Radiofrequency ablation: tissue destruction through delivery of electricity that produces ionic friction.
Louisiana will resume executions after a 15-year hiatus, forging ahead on plans set in motion last spring to carry out death sentences using nitrogen hypoxia.. The office of Louisiana Gov. Jeff ...
Another report from the same institution looked at almost two decades of patients who underwent radiofrequency ablation, cryoablation, or percutaneous ethanol injection for metastatic pheochromocytoma and reported that local control was achieved in over 85% of targeted lesions and that 92% of procedures were associated with reduced pain and/or ...
Valero Energy Corporation (NYSE:VLO) reported a fourth-quarter sales decline of 13.2% year-on-year to $30.76 billion, beating the analyst consensus estimate of $30.20 billion. The Refining segment ...